Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
InsideDesk has secured $12.6 million in growth financing led by Pender Ventures to accelerate its AI platform for dental revenue cycle management and support new hires across technical and commercial roles.
GW RhythmX has made its clinical AI platform RhythmX Pulse available on Microsoft Marketplace, integrating with Dragon Copilot to deliver real-time patient-specific recommendations directly within clinical workflows.
Autonomous Healthcare has received FDA De Novo marketing authorization for Syncron-E, the first device in a new category of ventilator waveform analysis software. The software assists respiratory therapists in detecting ineffective efforts in mechanically ventilated patients.
Brainify.AI has partnered with The Longevity Suite to debut Riyadh’s first luxury brain wellness assessment, introducing its AI based cognitive measurement platform to Saudi Arabia.
EHVA.ai has partnered with CareFactor to automate provider calls for eligibility verification, claims status, and benefits inquiries across medical, dental, and vision plans using its conversational voice AI platform.
Doceree has introduced Semmelweis, an AI model designed specifically for pharmaceutical commercialization, forming the intelligence layer beneath its Daily Command system and broader suite of tools.
THINK Surgical has entered a debt facility with Symbiotic Capital for up to $65 million in growth capital to support the expansion of its TMINI Miniature Robotic System.
Curve Dental has launched Curve Care+, a voice-driven clinical AI suite that streamlines documentation, charting, and periodontal workflows within its cloud-based dental practice management platform.
Sandiola has launched Sandpiper, an AI system for clinical documentation integrity designed for community hospitals and health systems. The tool reviews all inpatient encounters to ensure accurate patient acuity capture and optimize reimbursement.
Leica Biosystems has announced an agreement to acquire StatLab Medical Products, expanding its portfolio in anatomic pathology solutions. The deal is expected to close by the end of 2026, pending regulatory approval.
National University Hospital in Singapore will expand its use of smartwatch-based monitoring for inpatients after a successful pilot showed it could detect changes in vital signs earlier and reduce nurse workload.
410 Medical has raised $12 million in financing led by Orlando Health Ventures, with funds aimed at expanding commercial operations and launching the next version of its LifeFlow infuser in 2027.
Mission North has expanded its Health practice after achieving 33 percent year-over-year growth and appointed Alex Hunter as Executive Vice President of Health and Innovation. The move deepens the agency’s focus on healthcare, technology, and AI integration.
Newronika has received CE Mark certification for its adaptive deep brain stimulation system αDBS, which is now commercially approved across the European Economic Area and fully integrated with the company’s WebBioBank neural data platform.
ORTEC has acquired TOBA HR Solutions, a provider of workforce management software in Belgium and Luxembourg, expanding its healthcare customer base to over 250 organizations and 225,000 professionals.
RWS has introduced a new eCOA translation and linguistic validation service aimed at reducing delays in global clinical trials by combining licensing, translation, migration, and rater training under one unified program team.
Filevine has partnered with Codes Health to integrate AI based medical record retrieval directly into its legal work platform, accelerating record access for law firms.
Pulsenmore has been chosen to participate in Israel's Healthcare AI Regulatory Sandbox Program, backed by the Israel Innovation Authority and the Ministry of Health. The company will receive funding to advance AI-based tools for its home ultrasound platform, aimed at improving efficiency in prenatal care.
RyboDyn has received $1.3 million from the U.S. Department of War to advance two antibody therapies for lung cancer, supporting preclinical development of programs based on targets discovered through its AI-powered CypherAtlas platform.
Sanyou Biopharmaceuticals has released GEOTA 1.0, a new digital computing platform within its SAI-DA program that simplifies access to AI-driven research tools for drug development.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
